Key Documents

View All Documentation

159891

3-Methoxybenzylamine

Name: 3-Methoxybenzylamine
Brand: ALDRICH

98%

Select a Size

Change View

About This Item

Linear Formula:

CH₃OC₆H₄CH₂NH₂

CAS Number:

5071-96-5

Molecular Weight:

137.18

UNSPSC Code:

12352100

NACRES:

NA.22

PubChem Substance ID:

24849839

EC Number:

225-779-6

Beilstein/REAXYS Number:

1447182

MDL number:

MFCD00008115

Assay:

98%

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

Quality Level

100

assay

98%

refractive index

n20/D 1.547 (lit.)

bp

140 °C/37 mmHg (lit.)

density

1.072 g/mL at 25 °C (lit.)

functional group

amine

SMILES string

COc1cccc(CN)c1

InChI

1S/C8H11NO/c1-10-8-4-2-3-7(5-8)6-9/h2-5H,6,9H2,1H3

InChI key

GRRIMVWABNHKBX-UHFFFAOYSA-N

Description

Application

3-Methoxybenzylamine was used in the preparation of 6-substituted purines.

pictograms

GHS07

signalword

Warning

hcodes

H302,H315,H319,H335

pcodes

P261 - P264 - P271 - P301 + P312 - P302 + P352 - P305 + P351 + P338

Hazard Classifications

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

8A - Combustible corrosive hazardous materials

wgk

WGK 3

flash_point_f

235.4 °F - closed cup

flash_point_c

113 °C - closed cup

ppe

Eyeshields, Gloves, type ABEK (EN14387) respirator filter

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Synthesis and in vitro biological evaluation of 2,6,9-trisubstituted purines targeting multiple cyclin-dependent kinases.

Marek Zatloukal et al.

European journal of medicinal chemistry, 61, 61-72 (2012-07-10)

Several inhibitors of cyclin-dependent kinases (CDKs), including the 2,6,9-trisubstituted purine derivative roscovitine, are currently being evaluated in clinical trials as potential anticancer drugs. Here, we describe a new series of roscovitine derivatives that show increased potency in vitro. The series

Global Trade Item Number

SKU	GTIN
159891-5G	04061838744845
159891-1G	04061836817145